DIPHYSIO Study
Cross-source consensus on DIPHYSIO Study from 1 sources and 6 claims.
1 sources · 6 claims
Where it comes from
Other
Other
Other
Highlighted claims
- DIPHYSIO is a pilot multicentre open-label randomised controlled trial. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
- The trial is conducted at Queen Elizabeth II Jubilee Hospital and Logan Hospital within Metro South Health. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
- Ethics approval was granted by the Metro South Health Human Research Ethics Committee on 15 September 2025. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
- Research governance approval was granted by the Metro South Health Research Governance Office on 29 October 2025. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
- Recruitment is expected to begin in December 2025 and continue for up to 12 months or until 40 participants are enrolled. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
- Each participant has a 12-month follow-up period, and total study duration is expected to be up to 24 months. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol